Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hinnen

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Diabetes Care|January 29, 2011
Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program studyWilliam H Polonsky, Lawrence Fisher, Charles H Schikman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Clinical Chemistry and Laboratory Medicine|May 16, 2003
Which are the best tools for specific clinical application (chips, multiplex, mass spec profile, etc.)?M Ferrari, G Michel, D Foernzler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
Diabetes Technology & Therapeutics|May 17, 2011
A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP studyWilliam H Polonsky, Lawrence Fisher, Charles H Schikman, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 10, 2022
Comparison of the clinical performance of a hybrid Alba 4D and the AMC-4 locoregional hyperthermia systemsAkke Bakker, Remko Zweije, H Petra Kok, et al.
Physics and Imaging in Radiation Oncology|February 19, 2024
Virtual unenhanced dual-energy computed tomography for photon radiotherapy: The effect on dose distribution and cone-beam computed tomography based position verificationMaryam Afifah, Marloes C Bulthuis, Karin N Goudschaal, et al.
European Urology Oncology|April 26, 2025
Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment ModalityKatelijne C C de Bie, Lotte G Zuur, Dennie Meijer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Diabetes Care|January 29, 2011
Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program studyWilliam H Polonsky, Lawrence Fisher, Charles H Schikman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Clinical Chemistry and Laboratory Medicine|May 16, 2003
Which are the best tools for specific clinical application (chips, multiplex, mass spec profile, etc.)?M Ferrari, G Michel, D Foernzler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
Diabetes Technology & Therapeutics|May 17, 2011
A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP studyWilliam H Polonsky, Lawrence Fisher, Charles H Schikman, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 10, 2022
Comparison of the clinical performance of a hybrid Alba 4D and the AMC-4 locoregional hyperthermia systemsAkke Bakker, Remko Zweije, H Petra Kok, et al.
Physics and Imaging in Radiation Oncology|February 19, 2024
Virtual unenhanced dual-energy computed tomography for photon radiotherapy: The effect on dose distribution and cone-beam computed tomography based position verificationMaryam Afifah, Marloes C Bulthuis, Karin N Goudschaal, et al.
European Urology Oncology|April 26, 2025
Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment ModalityKatelijne C C de Bie, Lotte G Zuur, Dennie Meijer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Pageof 7